Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.75)
# 664
Out of 5,090 analysts
85
Total ratings
46.43%
Success rate
10.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.29 | +249.34% | 4 | Jun 4, 2025 | |
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.43 | +242.15% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.39 | +619.42% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $10.24 | +290.63% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.08 | +825.93% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $3.27 | +83.49% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.36 | +198.17% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $8.66 | +130.95% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.58 | +312.19% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $43.30 | +73.21% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $7.92 | +354.55% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $6 | $2.04 | +194.16% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.95 | +1,476.13% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.07 | +209.79% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $45.02 | +11.06% | 13 | Nov 26, 2024 |
ImmunityBio
Jun 4, 2025
Reiterates: Buy
Price Target: $8
Current: $2.29
Upside: +249.34%
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.43
Upside: +242.15%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $1.39
Upside: +619.42%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $10.24
Upside: +290.63%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.08
Upside: +825.93%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $3.27
Upside: +83.49%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.36
Upside: +198.17%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $8.66
Upside: +130.95%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.58
Upside: +312.19%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $43.30
Upside: +73.21%
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $7.92
Upside: +354.55%
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.04
Upside: +194.16%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.95
Upside: +1,476.13%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $8.07
Upside: +209.79%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $45.02
Upside: +11.06%